ThyroSeq v3 for Bethesda III and IV: An institutional experience
The benign call rate of the ThyroSeq v3 test is higher for nodules with Bethesda III cytology than for those with Bethesda IV cytology. In 96 surgically resected nodules, 45 unique molecular signat...
acsjournals.onlinelibrary.wiley.com